Literature DB >> 32609317

Telehealth for Substance-Using Populations in the Age of Coronavirus Disease 2019: Recommendations to Enhance Adoption.

Lewei Allison Lin1,2, Anne C Fernandez2, Erin E Bonar2,3.   

Abstract

Entities:  

Year:  2020        PMID： 32609317      PMCID： PMC8108064          DOI： 10.1001/jamapsychiatry.2020.1698

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  5 in total

Review 1.  Usefulness of telepsychiatry: A critical evaluation of videoconferencing-based approaches.

Authors:  Subho Chakrabarti
Journal:  World J Psychiatry       Date:  2015-09-22

2.  How Is Telemedicine Being Used In Opioid And Other Substance Use Disorder Treatment?

Authors:  Haiden A Huskamp; Alisa B Busch; Jeffrey Souza; Lori Uscher-Pines; Sherri Rose; Andrew Wilcock; Bruce E Landon; Ateev Mehrotra
Journal:  Health Aff (Millwood)       Date:  2018-12       Impact factor: 6.301

3.  Telemedicine-delivered treatment interventions for substance use disorders: A systematic review.

Authors:  Lewei Allison Lin; Danielle Casteel; Erin Shigekawa; Meghan Soulsby Weyrich; Dylan H Roby; Sara B McMenamin
Journal:  J Subst Abuse Treat       Date:  2019-03-21

Review 4.  Opioid substitution therapy: Lowering the treatment thresholds.

Authors:  Georgios Kourounis; Brian David Wensley Richards; Evdokia Kyprianou; Eva Symeonidou; Minerva-Melpomeni Malliori; Lampros Samartzis
Journal:  Drug Alcohol Depend       Date:  2015-12-30       Impact factor: 4.492

5.  Feasibility and Quit Rates of the Tobacco Status Project: A Facebook Smoking Cessation Intervention for Young Adults.

Authors:  Danielle E Ramo; Johannes Thrul; Kathryn Chavez; Kevin L Delucchi; Judith J Prochaska
Journal:  J Med Internet Res       Date:  2015-12-31       Impact factor: 5.428
  5 in total
  26 in total

1.  Treatment of Opioid Use Disorder Among Commercially Insured Patients in the Context of the COVID-19 Pandemic.

Authors:  Haiden A Huskamp; Alisa B Busch; Lori Uscher-Pines; Michael L Barnett; Lauren Riedel; Ateev Mehrotra
Journal:  JAMA       Date:  2020-12-15       Impact factor: 56.272

2.  Impact of COVID-19 Telehealth Policy Changes on Buprenorphine Treatment for Opioid Use Disorder.

Authors:  Lewei Allison Lin; Lan Zhang; Hyungjin Myra Kim; Madeline C Frost
Journal:  Am J Psychiatry       Date:  2022-07-28       Impact factor: 19.242

3.  Effectiveness of a Stand-alone Telephone-Delivered Intervention for Reducing Problem Alcohol Use: A Randomized Clinical Trial.

Authors:  Dan I Lubman; Jasmin Grigg; John Reynolds; Kate Hall; Amanda L Baker; Petra K Staiger; Jonathan Tyler; Isabelle Volpe; Peta Stragalinos; Anthony Harris; David Best; Victoria Manning
Journal:  JAMA Psychiatry       Date:  2022-09-21       Impact factor: 25.911

4.  Impacts of COVID-19 on residential treatment programs for substance use disorder.

Authors:  Anna Pagano; Sindhu Hosakote; Kwinoja Kapiteni; Elana R Straus; Jessie Wong; Joseph R Guydish
Journal:  J Subst Abuse Treat       Date:  2020-12-17

5.  Use of Video Telehealth Tablets to Increase Access for Veterans Experiencing Homelessness.

Authors:  Lynn A Garvin; Jiaqi Hu; Cindie Slightam; D Keith McInnes; Donna M Zulman
Journal:  J Gen Intern Med       Date:  2021-05-23       Impact factor: 6.473

Review 6.  Methamphetamine use in the United States: epidemiological update and implications for prevention, treatment, and harm reduction.

Authors:  Christopher M Jones; Debra Houry; Beth Han; Grant Baldwin; Alana Vivolo-Kantor; Wilson M Compton
Journal:  Ann N Y Acad Sci       Date:  2021-09-24       Impact factor: 6.499

7.  Psychological and Demographic Determinants of Substance Use and Mental Health During the COVID-19 Pandemic.

Authors:  Fatima Mougharbel; Hugues Sampasa-Kanyinga; Brandon Heidinger; Kim Corace; Hayley A Hamilton; Gary S Goldfield
Journal:  Front Public Health       Date:  2021-06-25

8.  Digital delivery of a contingency management intervention for substance use disorder: A feasibility study with DynamiCare Health.

Authors:  Alexis S Hammond; Mary M Sweeney; Tanyaradzwa U Chikosi; Maxine L Stitzer
Journal:  J Subst Abuse Treat       Date:  2021-04-21

9.  Comparing telemedicine to in-person buprenorphine treatment in U.S. veterans with opioid use disorder.

Authors:  Lewei A Lin; John C Fortney; Amy S B Bohnert; Lara N Coughlin; Lan Zhang; John D Piette
Journal:  J Subst Abuse Treat       Date:  2021-05-28

10.  Impact of the Coronavirus Pandemic on Substance Use Disorder Treatment: Findings from a Survey of Specialty Providers in California.

Authors:  Kristen Henretty; Howard Padwa; Katherine Treiman; Marylou Gilbert; Tami L Mark
Journal:  Subst Abuse       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.